The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

A nurse-led intervention had a greater effect on dyspnea among patients with advanced lung cancer who experienced improvement in their psychological distress.

Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

John Heymach, MD, PhD, The University of Texas MD Anderson Cancer Center, discusses the promising results of zongertinib for HER2-mutated non–small cell lung cancer, showcasing high response rates and ...

Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech specializing in developing innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies for cancer ...

A Cramlington mum who was diagnosed with cancer six weeks after giving birth to her second child says that "making memories ...

A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.